Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn M Lucas

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
The British Journal of Nutrition|May 7, 2016
Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adultsLucinda J Black, Sally Burrows, Robyn M Lucas, et al.
Multiple Sclerosis and Related Disorders|December 2, 2021
A proinflammatory diet is associated with an increased likelihood of first clinical diagnosis of central nervous system demyelination in womenAdriana Mannino, Fiona E Lithander, Eleanor Dunlop, et al.
Neonatology|October 19, 2016
Determinants of Neonatal Vitamin D Levels as Measured on Neonatal Dried Blood Spot SamplesChloe A Smith, Cong Sun, Angela Pezic, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2013
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradientRobyn M Lucas, Anne-Louise Ponsonby, Keith Dear, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
Multiple Sclerosis and Related Disorders|November 11, 2019
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic reviewWolfgang Marx, Meghan Hockey, Amelia J McGuinness, et al.
Frontiers in Immunology|July 31, 2018
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated SyndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Latitudinal variation in incidence and type of first central nervous system demyelinating eventsBruce V Taylor, Robyn M Lucas, Keith Dear, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D<sub>3</sub> supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 22, 2018
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS studyPrue H Hart, Anderson P Jones, Stephanie Trend, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
The British Journal of Nutrition|May 7, 2016
Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adultsLucinda J Black, Sally Burrows, Robyn M Lucas, et al.
Multiple Sclerosis and Related Disorders|December 2, 2021
A proinflammatory diet is associated with an increased likelihood of first clinical diagnosis of central nervous system demyelination in womenAdriana Mannino, Fiona E Lithander, Eleanor Dunlop, et al.
Neonatology|October 19, 2016
Determinants of Neonatal Vitamin D Levels as Measured on Neonatal Dried Blood Spot SamplesChloe A Smith, Cong Sun, Angela Pezic, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2013
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradientRobyn M Lucas, Anne-Louise Ponsonby, Keith Dear, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
Multiple Sclerosis and Related Disorders|November 11, 2019
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic reviewWolfgang Marx, Meghan Hockey, Amelia J McGuinness, et al.
Frontiers in Immunology|July 31, 2018
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated SyndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Latitudinal variation in incidence and type of first central nervous system demyelinating eventsBruce V Taylor, Robyn M Lucas, Keith Dear, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D<sub>3</sub> supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 22, 2018
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS studyPrue H Hart, Anderson P Jones, Stephanie Trend, et al.
Pageof 18